Franklin Biotechnology Discv Z(acc)GBP (FUND:B76CRG3) - Fund price


Fund Report

Franklin Biotechnology Discovery Fund Z(acc)GBP

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)3.18 GBP
(31/08/2019)
Fund Size (mil)1,692.80 USD
(30/08/2019)
Mkt Cap % 31/08/2019
FundCat
Giant8.076.05
Large29.9229.11
Medium24.2435.90
Small33.3427.71
Micro4.431.23
Valuations and Growth Rates 31/08/2019
FundCategory
Price / Earnings14.0016.44
Price/Book4.043.03
Price/Sales5.025.01
Price/Cash Flow12.9211.98
Dividend-Yield Factor0.550.44
Long-Term Projected Earnings Growth10.0015.85
Historical Earnings Growth19.5624.40
Sales Growth13.0614.79
Cash-Flow Growth1.525.73
Book-Value Growth7.6412.39

Asset Allocation % 31/08/2019

Asset Allocation
LongShortNetCat
Stocks93.670.0093.67100.05
Bonds0.000.000.000.00
Cash5.790.005.79-1.07
Other0.540.000.541.02
World Regions % 31/08/2019
FundCategory
Greater Europe7.568.53
United Kingdom4.091.78
Eurozone2.724.08
Europe - ex Euro0.752.48
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.19
Americas92.4489.16
United States91.4888.97
Canada0.960.19
Latin America0.000.00
Greater Asia0.002.32
Japan0.000.75
Australasia0.000.08
Asia - Developed0.000.30
Asia - Emerging0.001.19
Stock Sector Weightings % 31/08/2019
FundCategory
Cyclical0.000.00
Basic Materials-0.00
Consumer Cyclical--
Financial Services--
Real Estate-0.00
Sensitive0.003.78
Communication Services--
Energy--
Industrials-0.33
Technology-3.44
Defensive100.0096.22
Consumer Defensive-0.22
Healthcare100.0096.00
Utilities--

Top 10 Holdings31/08/2019

Assets in Top 10 Holdings %46.52
Total Number of Equity Holdings73
Total Number of Bond Holdings0
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
IncreaseAmgen Inc HealthcareUnited States7.56
IncreaseVertex Pharmaceuticals Inc HealthcareUnited States6.18
IncreaseAlexion Pharmaceuticals Inc HealthcareUnited States5.57
IncreaseGilead Sciences Inc HealthcareUnited States5.13
Illumina Inc HealthcareUnited States4.36
IncreaseGW Pharmaceuticals PLC ADR HealthcareUnited Kingdom3.83
Iovance Biotherapeutics Inc HealthcareUnited States3.74
Biogen Inc HealthcareUnited States3.71
New since last portfolioUnited States Treasury Bills 0% 2019-09-03Not ClassifiedUnited States3.24
Biomarin Pharmaceutical Inc HealthcareUnited States3.20
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.